Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

Rekombinanter SARS-CoV-2 Nucleocapsid Antikörper (Whole Molecule)

Animal-Free SARS-CoV-2 N Reaktivität: SARS Coronavirus-2 (SARS-CoV-2) ELISA, WB, IF, FACS Wirt: Maus Monoclonal AB79-E11 unconjugated Recombinant Antibody
Produktnummer ABIN7581774
  • Target Alle SARS-CoV-2 Nucleocapsid (SARS-CoV-2 N) Antikörper anzeigen
    SARS-CoV-2 Nucleocapsid (SARS-CoV-2 N)
    Antikörpertyp
    Recombinant Antibody
    Bindungsspezifität
    • 18
    • 3
    • 2
    • 2
    • 1
    • 1
    Whole Molecule
    Reaktivität
    • 79
    • 8
    • 4
    • 3
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    SARS Coronavirus-2 (SARS-CoV-2)
    Wirt
    • 32
    • 25
    • 24
    • 4
    • 1
    • 1
    Maus
    Expressionssystem
    Phage display
    Klonalität
    • 65
    • 15
    • 6
    Monoklonal
    Konjugat
    • 69
    • 10
    • 5
    • 1
    • 1
    Dieser SARS-CoV-2 Nucleocapsid Antikörper ist unkonjugiert
    Applikation
    • 76
    • 37
    • 11
    • 9
    • 7
    • 6
    • 4
    • 4
    • 4
    • 4
    • 4
    • 3
    • 3
    • 3
    • 3
    • 3
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    ELISA, Western Blotting (WB), Immunofluorescence (IF), Flow Cytometry (FACS)
    Verwendungszweck
    recombinant anti-SARS-CoV-2 Nucleocapsid protein antibody
    Spezifität
    This is an antibody developed by antibody phage display technology using a human naive antibody gene library and SARS-CoV-2 antigen. For this antibody both the heavy and light chains are cloned and expressed, generating full-length antibodies.
    Kreuzreaktivität (Details)
    SARS-CoV1 N-protein
    Produktmerkmale
    This antibody can be detected with anti-mouse Fc secondary antibodies.
    Aufreinigung
    Protein A purification
    Güteklasse
    Animal-Free
    Immunogen
    No immunization, animal-free antibody development. Antigen: Nucleocapsid protein: MSDNGPQSNQRSAPRITFGGPTDSTDNNQNGGRNGARPKQRRPQGLPNNTASWFTALTQHGKEELRFPRGQGVPINTNSGPDDQIGYYRRATRRVRGGDGKMKELSPRWYFYYLGTGPEASLPYGANKEGIVWVATEGALNTPKDHIGTRNPNNNAATVLQLPQGTTLPKGFYAEGSRGGSQASSRSSSRSRGNSRNSTPGSSRGNSPARMASGGGETALALLLLDRLNQLESKVSGKGQQQQGQTVTKKSAAEASKKPRQKRTATKQYNVTQAFGRRGPEQTQGNFGDQDLIRQGTDYKHWPQIAQFAPSASAFFGMSRIGMEVTPSGTWLTYHGAIKLDDKDPQFKDNVILLNKHIDAYKTFPPTEPKKDKKKKTDEAQPLPQRQKKQPTVTLLPAADMDDFSRQLQNSMSGASADSTQA
    Klon
    AB79-E11
    Isotyp
    IgG2a
    Top Product
    Discover our top product SARS-CoV-2 N Primärantikörper
  • Applikationshinweise
    Western Blot: 0.2-5 μg/mL ELISA: 1-12 μg/mL as coating antibody 0.5-5 μg/mL as detection antibody IF: 0.1 - 10 μg/mL Optimal working dilution should be determined by the investigator
    Beschränkungen
    Nur für Forschungszwecke einsetzbar
  • Format
    Liquid
    Konzentration
    1 mg/mL
    Buffer
    PBS, pH 7.4,
    Lagerung
    -20 °C
  • Target
    SARS-CoV-2 Nucleocapsid (SARS-CoV-2 N)
    Andere Bezeichnung
    SARS-CoV-2 Nucleocapsid protein (NP) (SARS-CoV-2 N Produkte)
    Hintergrund
    Coronaviruses (CoVs) are enveloped non-segmented positive-sense single-stranded RNA viruses and can infect respiratory, gastrointestinal, hepatic and central nervous system of human and many other wild animals. Recently, a new severe acute respiratory syndrome β-coronavirus called SARS-CoV-2 (or 2019-nCoV) has emerged, which causes an epidemic of acute respiratory syndrome (called coronavirus human disease 2019 or COVID-19). SARS-CoV-2 shares 79.5 % sequence identity with SARS-CoV and is 96.2 % identical at the genome level to the bat coronavirus BatCoV RaTG133, suggesting it had originated in bats. SARS-CoV-2 contains 4 structural proteins, including Envelope (E), Membrane (M), Nucleocapsid (N) and Spike (S), which is a transmembrane protein, composed of two subunits S1 and S2. The S protein plays a key role in viral infection and pathogenesis. The S1 subunit contains the N-terminal domain (NTD) and a receptor binding domain (RBD), which binds to the cell surface receptor Angiotensin-Converting Enzyme 2 (ACE2) present at the surface of epithelial cells, causing mainly infection of human respiratory cells, whereas S2 harbors heptad repeat 1 (HR1) and HR2. The RBD domain first binds its receptor to form an RBD/ACE2 complex. This triggers conformational changes in the S protein, leading to membrane fusion mediated via HR1 and HR2 and consequently in viral entry into target cells. Antibodies targeting various regions of S protein have different mechanisms in inhibiting SARS-CoV-2 infection. For example, NTD-targeting antibodies bind the NTD to form an NTD/mAb complex, thereby preventing conformational changes in the S protein and blocking membrane fusion and viral entry. RBD-targeting antibodies form RBD/mAb or RBD/Nb complexes that could inhibit binding of the RBD to ACE2, thereby preventing entry of SARS-CoV-2 into target cells.
    Molekulargewicht
    25 kDa
    NCBI Accession
    NP_828858
    UniProt
    P59595
Sie sind hier:
Kundenservice